No metabolic derangement, insulin sensitivity preserved; fat on the macrometabolic level can look fit. Now, let's look deeper.
Obesity Advocacy Groups Say Exclusion of People with Obesity from Drug Research Must Stop
The 5 leading advocacy groups said the safety of people with obesity is at risk and called on the FDA to change clinical trial inclusion requirements and expedite labeling changes.
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.
Daily Dose: Lowering SBP to <120 mm Hg Reduces CV Event Risk
Your daily dose of the clinical news you may have missed.
Obesity & Type 2 Diabetes: An Expert Discussion
In our latest episode, 2 obesity experts discuss the importance of early intervention to reduce risk for complications, suggestions for managing patients in primary care, and more.
Daily Dose: Semaglutide Cuts CV Risk by 20% in Adults with Obesity, CVD and Without DM
Cutting Daily Sodium Intake Significantly Lowers Blood Pressure in 1 Week, According to New Research
AHA 2023: Reducing daily sodium intake by about 4000 mg significantly lowered SBP in approximately 73% of adults in 1 week when compared to a higher sodium diet.